• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
"I Want to Know Everything ...  ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.“我想知道一切……”:腰椎穿刺可接受性中的研究结果回报和透明度的重要性,针对非裔美国老年人群体。
J Alzheimers Dis. 2023;95(2):663-675. doi: 10.3233/JAD-230275.
2
Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research.与阿尔茨海默病研究中腰椎穿刺参与相关的因素。
J Alzheimers Dis. 2020;77(4):1559-1567. doi: 10.3233/JAD-200394.
3
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.哪些因素影响黑人和非裔美国人参与临床前期阿尔茨海默病生物标志物研究的意愿?一项定性情境分析。
J Alzheimers Dis. 2022;87(3):1167-1179. doi: 10.3233/JAD-215521.
4
Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.了解健康志愿者和代表性不足社区成员报名参加移动响应注册以参与阿尔茨海默病预防研究的障碍和促进因素。
J Prev Alzheimers Dis. 2023;10(4):865-874. doi: 10.14283/jpad.2023.67.
5
The Community Engaged Digital Alzheimer's Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry.社区参与式数字阿尔茨海默病研究(CEDAR):一项数字干预措施,旨在增加美国黑人参与者在大脑健康注册中心的研究参与度。
J Prev Alzheimers Dis. 2023;10(4):847-856. doi: 10.14283/jpad.2023.32.
6
Barriers and facilitators of African American participation in Alzheimer disease biomarker research.非裔美国人参与阿尔茨海默病生物标志物研究的障碍和促进因素。
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl(Suppl):S24-9. doi: 10.1097/WAD.0b013e3181f14a14.
7
A Mini-Review of Strategies for Recruiting Older African Americans to Alzheimer's Disease Research.招募老年非裔美国人参与阿尔茨海默病研究的策略简述。
Community Health Equity Res Policy. 2024 Jul;44(4):419-428. doi: 10.1177/0272684X221118493. Epub 2022 Sep 18.
8
Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.为什么在血浆阿尔茨海默病生物标志物的发现中需要考虑包容性。
J Alzheimers Dis. 2021;79(3):1327-1344. doi: 10.3233/JAD-201318.
9
Perceptions of Caring Recruitment Among Older Adults: African Americans and Non-Latinx Whites.老年人对关怀招聘的看法:非裔美国人和非拉丁裔白人。
Nurs Res. 2023;72(2):114-122. doi: 10.1097/NNR.0000000000000640. Epub 2022 Dec 16.
10
Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience.非裔美国人和高加索人腰椎穿刺研究:认知决定体验。
Front Aging Neurosci. 2016 Dec 2;8:296. doi: 10.3389/fnagi.2016.00296. eCollection 2016.

引用本文的文献

1
Association between Trust of Researchers and Willingness to Participate in Alzheimer's Disease Biomarker Research.研究人员的信任与参与阿尔茨海默病生物标志物研究意愿之间的关联。
Alzheimers Dement Behav Socioecon Aging. 2025 Sep;1(3). doi: 10.1002/bsa3.70024. Epub 2025 Jul 1.
2
Communicating the risk of dementia: a scoping review.痴呆症风险的沟通:一项范围综述
BMJ Neurol Open. 2025 Jul 22;7(2):e001138. doi: 10.1136/bmjno-2025-001138. eCollection 2025.
3
Genetic and biomarker disclosure process in a memory and aging study.记忆与衰老研究中的基因和生物标志物披露过程。
J Alzheimers Dis. 2025 Mar;104(2):312-318. doi: 10.1177/13872877251315957. Epub 2025 Feb 9.
4
Returning individual research results to participants: Values, preferences, and expectations.向参与者反馈个体研究结果:价值观、偏好与期望。
J Clin Transl Sci. 2024 Sep 18;8(1):e126. doi: 10.1017/cts.2024.568. eCollection 2024.
5
"My Blood, You Know, My Biology Being out There…": Consent and Participant Control of Biological Samples.“我的血液,你知道,我的生物学特征在那里……”:生物样本的同意和参与者控制。
J Empir Res Hum Res Ethics. 2024 Feb;19(1-2):3-15. doi: 10.1177/15562646231222665. Epub 2024 Jan 8.

本文引用的文献

1
"My Blood, You Know, My Biology Being out There…": Consent and Participant Control of Biological Samples.“我的血液,你知道,我的生物学特征在那里……”:生物样本的同意和参与者控制。
J Empir Res Hum Res Ethics. 2024 Feb;19(1-2):3-15. doi: 10.1177/15562646231222665. Epub 2024 Jan 8.
2
Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And Justification.将残疾人排除在临床研究之外:资格标准缺乏清晰度和正当性。
Health Aff (Millwood). 2022 Oct;41(10):1423-1432. doi: 10.1377/hlthaff.2022.00520.
3
Opening the door to university health research: recommendations for increasing accessibility for individuals with intellectual disability.为大学健康研究敞开大门:增加智力残疾个体可及性的建议。
Int J Equity Health. 2022 Sep 10;21(1):130. doi: 10.1186/s12939-022-01730-4.
4
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.哪些因素影响黑人和非裔美国人参与临床前期阿尔茨海默病生物标志物研究的意愿?一项定性情境分析。
J Alzheimers Dis. 2022;87(3):1167-1179. doi: 10.3233/JAD-215521.
5
"There's not much we can do…" researcher-level barriers to the inclusion of underrepresented participants in translational research.“我们能做的不多……”:在转化研究中纳入代表性不足参与者时的研究者层面障碍。
J Clin Transl Sci. 2021 Nov 11;6(1):e4. doi: 10.1017/cts.2021.876. eCollection 2022.
6
Fair payment and just benefits to enhance diversity in clinical research.合理报酬与公平福利以促进临床研究的多样性。
J Clin Transl Sci. 2021 Jul 14;5(1):e159. doi: 10.1017/cts.2021.816. eCollection 2021.
7
Recruitment and retention of underrepresented and vulnerable populations to research.代表性不足和脆弱人群的招募和保留参与研究。
Public Health Nurs. 2021 Nov;38(6):1102-1115. doi: 10.1111/phn.12943. Epub 2021 Jul 8.
8
Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound.将代表性不足的群体纳入临床前阿尔茨海默病试验——机会众多。
JAMA Netw Open. 2021 Jul 1;4(7):e2114606. doi: 10.1001/jamanetworkopen.2021.14606.
9
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know.临床前阿尔茨海默病生物标志物结果在研究和临床环境中的披露:为何披露、如何披露以及我们仍需了解的内容。
Alzheimers Dement (Amst). 2021 Feb 20;13(1):e12150. doi: 10.1002/dad2.12150. eCollection 2021.
10
The Urgency of Justice in Research: Beyond COVID-19.研究中的正义紧迫性:超越 COVID-19。
Trends Mol Med. 2021 Feb;27(2):97-100. doi: 10.1016/j.molmed.2020.11.004. Epub 2020 Nov 17.

“我想知道一切……”:腰椎穿刺可接受性中的研究结果回报和透明度的重要性,针对非裔美国老年人群体。

"I Want to Know Everything ...  ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.

机构信息

Collaborative Center for Health Equity, Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.

School of Nursing, University of Wisconsin, Madison, WI, USA.

出版信息

J Alzheimers Dis. 2023;95(2):663-675. doi: 10.3233/JAD-230275.

DOI:10.3233/JAD-230275
PMID:37574732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10637283/
Abstract

BACKGROUND

Although African Americans experience the highest risk of Alzheimer's disease (AD), they are dramatically underrepresented in preclinical biomarker research. This is especially true for studies involving lumbar puncture as it may involve more perceived risk even for those participants who are otherwise supportive of research.

OBJECTIVE

To understand the unique concerns of African American participants regarding biomarker studies involving lumbar puncture who demonstrate support for AD research.

METHODS

Study participants were African American adults contacted through an AD research registry. We employed a novel method used to create hypothetical research studies varying on a set number of factors. The method is designed to collect potential patterns in decision making regarding research participation but differs from experimental vignette design in that the survey is administered with an accompanying qualitive interview to determine the meaning participants ascribe to factors independently and in conjunction with one another.

RESULTS

Sixty-one participants each reviewed three randomly selected research scenarios and created their "ideal" study involving lumbar puncture. Scenario variables included: disclosure of research results, racial and ethnic identity of the researcher, recruitment method, and amount of incentive.

CONCLUSION

Findings indicate that transparency in the return of AD research results to be the strongest driver of participation, followed by race of the researcher and amount of incentive. Recruitment method had limited impact on hypothetical decision making.

摘要

背景

尽管非裔美国人患阿尔茨海默病(AD)的风险最高,但他们在临床前生物标志物研究中代表性严重不足。对于涉及腰椎穿刺的研究来说尤其如此,因为即使对于那些原本支持研究的参与者来说,这也可能涉及更多的感知风险。

目的

了解对 AD 研究表示支持,但对涉及腰椎穿刺的生物标志物研究有特殊顾虑的非裔美国参与者的独特关注点。

方法

通过 AD 研究登记册联系非裔美国成年人作为研究参与者。我们采用了一种新的方法来创建假设的研究,这些研究在一组因素上有所不同。该方法旨在收集有关研究参与决策的潜在模式,但与实验情境设计不同,因为该调查是在伴随定性访谈的情况下进行的,以确定参与者各自以及共同赋予因素的含义。

结果

61 名参与者每人都审查了三个随机选择的研究场景,并创建了他们理想的涉及腰椎穿刺的研究。情景变量包括:研究结果的披露、研究人员的种族和民族身份、招募方法和激励金额。

结论

研究结果表明,向参与者返还 AD 研究结果的透明度是参与的最强驱动力,其次是研究人员的种族和激励金额。招募方法对假设决策的影响有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/3744c19ac58e/nihms-1940578-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/6d564308626e/nihms-1940578-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/f19a09edee65/nihms-1940578-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/3744c19ac58e/nihms-1940578-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/6d564308626e/nihms-1940578-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/f19a09edee65/nihms-1940578-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5fc/10637283/3744c19ac58e/nihms-1940578-f0003.jpg